Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer International Publishing

9783319568041, 9783319568058

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Posttranslational Modifications and Death Receptor Signalling

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_11 ◽

2017 ◽

pp. 247-290

Author(s):

Olivier Micheau

Keyword(s):

Posttranslational Modifications ◽

Death Receptor ◽

Receptor Signalling

Download Full-text

TRAIL-R3/R4 and Inhibition of TRAIL Signalling in Cancer

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_2 ◽

2017 ◽

pp. 27-57

Author(s):

Lubna Danish ◽

Daniela Stöhr ◽

Peter Scheurich ◽

Nadine Pollak

Download Full-text

System Modeling of Receptor-Induced Apoptosis

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_12 ◽

2017 ◽

pp. 291-307 ◽

Cited By ~ 1

Author(s):

François Bertaux ◽

Dirk Drasdo ◽

Grégory Batt

Keyword(s):

System Modeling ◽

Induced Apoptosis

Download Full-text

Regulation of Caspase-Mediated Apoptosis by the Tumor Suppressor Par-4

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_5 ◽

2017 ◽

pp. 91-106

Author(s):

James Sledziona ◽

Vivek M. Rangnekar

Keyword(s):

Tumor Suppressor

Download Full-text

Bcl-2 Proteins and TRAIL Resistance in Melanoma

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_4 ◽

2017 ◽

pp. 79-90 ◽

Cited By ~ 1

Author(s):

Jürgen Eberle

Keyword(s):

Trail Resistance

Download Full-text

TLR3 Is a Death Receptor Target in Cancer Therapy

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_8 ◽

2017 ◽

pp. 159-185

Author(s):

Yann Estornes ◽

Toufic Renno ◽

Serge Lebecque

Keyword(s):

Cancer Therapy ◽

Death Receptor

Download Full-text

Role of Sphingolipids in Death Receptor Signalling

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_10 ◽

2017 ◽

pp. 229-245

Author(s):

Fatima Bilal ◽

Michaël Pérès ◽

Nathalie Andrieu-Abadie ◽

Thierry Levade ◽

Bassam Badran ◽

...

Keyword(s):

Death Receptor ◽

Receptor Signalling

Download Full-text

Resistance to TRAIL Pathway-Targeted Therapeutics in Cancer

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_1 ◽

2017 ◽

pp. 1-25 ◽

Cited By ~ 1

Author(s):

Jessica Wagner ◽

Christina Leah Kline ◽

Wafik El-Deiry

Keyword(s):

Targeted Therapeutics

Download Full-text

Stem Cell Regulation by Death Ligands and Their Use in Cell Therapy

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_6 ◽

2017 ◽

pp. 107-129

Author(s):

Andrea Mohr ◽

Ralf Zwacka

Keyword(s):

Stem Cell ◽

Cell Therapy ◽

Cell Regulation ◽

Stem Cell Regulation

Download Full-text

IAPs and Resistance to Death Receptors in Cancer

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer ◽

10.1007/978-3-319-56805-8_3 ◽

2017 ◽

pp. 59-77

Author(s):

Laurence Dubrez ◽

Simone Fulda

Keyword(s):

Death Receptors

Download Full-text

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in CancerLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer International Publishing

Posttranslational Modifications and Death Receptor Signalling

TRAIL-R3/R4 and Inhibition of TRAIL Signalling in Cancer

System Modeling of Receptor-Induced Apoptosis

Regulation of Caspase-Mediated Apoptosis by the Tumor Suppressor Par-4

Bcl-2 Proteins and TRAIL Resistance in Melanoma

TLR3 Is a Death Receptor Target in Cancer Therapy

Role of Sphingolipids in Death Receptor Signalling

Resistance to TRAIL Pathway-Targeted Therapeutics in Cancer

Stem Cell Regulation by Death Ligands and Their Use in Cell Therapy

IAPs and Resistance to Death Receptors in Cancer

Resistance to Targeted Anti-Cancer Therapeutics - TRAIL, Fas Ligand, TNF and TLR3 in Cancer
Latest Publications